http://www.mmm-online.com/product/topic/204/ Articles tagged with Product from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no Researchers said a new kind of cholesterol-modifying drug from Merck demonstrated remarkably strong LDL-lowering and HDL-raising effects, and appeared safe from a cardiovascular standpoint, stoking doctors' optimism that it could reach market. http://www.mmm-online.com/mercks-anacetrapib-has-curiously-strong-effect-on-lipids/article/191124/ Thu, 18 Nov 2010 16:54:07 GMT Researchers said a new kind of cholesterol-modifying drug from Merck demonstrated remarkably strong LDL-lowering and HDL-raising effects, and appeared safe from a cardiovascular standpoint, stoking doctors' optimism that it could reach market. MMM Phase III data reported yesterday at the AHA Meeting in Chicago showed that new blood thinner Xarelto (rivaroxaban) stacks up well against warfarin in preventing strokes in patients with atrial fibrillation. http://www.mmm-online.com/xarelto-proves-itself-against-warfarin/article/190966/ Tue, 16 Nov 2010 20:02:21 GMT Phase III data reported yesterday at the AHA Meeting in Chicago showed that new blood thinner Xarelto (rivaroxaban) stacks up well against warfarin in preventing strokes in patients with atrial fibrillation. MMM A love-hate relationship for Coumadin (warfarin) is playing out online, say authors of a new report that may offer lessons for marketers of new blood-thinning products. http://www.mmm-online.com/in-coumadin-banter-lessons-for-marketers-of-new-blood-thinners/article/181809/ Wed, 27 Oct 2010 15:03:16 GMT A love-hate relationship for Coumadin (warfarin) is playing out online, say authors of a new report that may offer lessons for marketers of new blood-thinning products. MMM Generics and specialty pharma Watson acquired a progesterone gel, marketed as Crinone and Prochieve, and added roughly 19 reps to its women's health sales force. Watson now employs close to 400 reps, according to Charlie Mayr, a company spokesperson. http://www.mmm-online.com/watson-beefs-up-womens-health-biz-adds-reps/article/174488/ Tue, 13 Jul 2010 17:06:00 GMT Generics and specialty pharma Watson acquired a progesterone gel, marketed as Crinone and Prochieve, and added roughly 19 reps to its women's health sales force. Watson now employs close to 400 reps, according to Charlie Mayr, a company spokesperson. MMM To those who believe we have everything we need in the lipid-lowering world, Ben Stakely, Kowa Pharmaceuticals America (KPA) CEO and president, has one thing to say: "I would argue with you." http://www.mmm-online.com/kowas-us-ceo-says-new-statin-holds-appeal-for-untreated-patients/article/173172/ Thu, 24 Jun 2010 19:56:32 GMT To those who believe we have everything we need in the lipid-lowering world, Ben Stakely, Kowa Pharmaceuticals America (KPA) CEO and president, has one thing to say: "I would argue with you." MMM A report predicting that Humira will become the world's biggest product in two years' time generated positive news for the Abbott Labs arthritis drug. Several factors are driving the bullish forecast. http://www.mmm-online.com/whats-behind-humiras-bullish-forecast/article/169449/ Tue, 04 May 2010 19:45:07 GMT A report predicting that Humira will become the world's biggest product in two years' time generated positive news for the Abbott Labs arthritis drug. Several factors are driving the bullish forecast. MMM Sanofi-Aventis partnered with Cegedim Dendrite to launch a CRM mobile platform for its managed market managers. The three-year agreement spans 28 countries, including the US, France and Japan. http://www.mmm-online.com/sanofi-cegedim-launch-mobile-crm-for-managed-markets/article/138179/ Mon, 08 Jun 2009 21:48:29 GMT Sanofi-Aventis partnered with Cegedim Dendrite to launch a CRM mobile platform for its managed market managers. The three-year agreement spans 28 countries, including the US, France and Japan. MMM If you still haven't entered the MM&M Awards 2009, then you'd better move fast--today (June 5) is the final deadline for submissions. http://www.mmm-online.com/last-chance-to-grab-glory/article/138007/ Thu, 04 Jun 2009 17:00:10 GMT If you still haven't entered the MM&M Awards 2009, then you'd better move fast--today (June 5) is the final deadline for submissions. MMM AstraZeneca will help Abbott reach more physicians with its Trilipix (fenofibric acid) drug, a cholesterol product approved by FDA last December. The companies also filed an NDA for Certriad, a Trilipix/Crestor combination drug. http://www.mmm-online.com/abbott-az-extend-co-promotion-to-trilipix/article/138003/ Thu, 04 Jun 2009 15:58:19 GMT AstraZeneca will help Abbott reach more physicians with its Trilipix (fenofibric acid) drug, a cholesterol product approved by FDA last December. The companies also filed an NDA for Certriad, a Trilipix/Crestor combination drug. MMM GlaxoSmithKline will partner with Shire to co-promote Vyvanse, Shire's Adderall follow-on ADHD drug. The three-year deal will double the brand's sales force, with 600 GSK reps targeting primary care physicians and specialists, the companies announced today. http://www.mmm-online.com/gsk-to-co-promote-shires-vyvanse/article/129741/ Tue, 31 Mar 2009 14:57:46 GMT GlaxoSmithKline will partner with Shire to co-promote Vyvanse, Shire's Adderall follow-on ADHD drug. The three-year deal will double the brand's sales force, with 600 GSK reps targeting primary care physicians and specialists, the companies announced today. MMM